August 01, 2014 9:22 PM ET

Pharmaceuticals

Company Overview of Azelon Pharmaceuticals, Inc.

Company Overview

Azelon Pharmaceuticals, Inc. focuses on the development of formulations for the treatment of osteoporosis. It develops ZT-034, a nasal spray formulation of teriparatide that offers an alternate for patients at high risk of fracture. Azelon Pharmaceuticals, Inc. was formerly known as Zelos Therapeutics, Inc. The company was founded in 2000 and is based in West Conshohocken, Pennsylvania.

200 Barr Harbor Drive

Four Tower Bridge

Suite 400

West Conshohocken, PA 19428

United States

Founded in 2000

Phone:

610-260-6045

Fax:

610-567-2044

Key Executives for Azelon Pharmaceuticals, Inc.

Chief Executive Officer and President
Executive Chairman
Age: 58
Vice President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
OncoPep, Inc. United States
Viamet Pharmaceuticals Holdings, LLC United States
Seldar Pharma, Inc. United States
Variant Pharmaceuticals, Inc. United States
Interleukin Brands, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Azelon Pharmaceuticals, Inc., please visit www.azelon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.